Mathias Oelke - 22 Nov 2022 Form 4 Insider Report for NexImmune, Inc.

Role
Chief Science Officer
Signature
/s/ John Rudy, Attorney-in-fact
Issuer symbol
NEXI on OTC
Transactions as of
22 Nov 2022
Net transactions value
$0
Form type
4
Filing time
25 Nov 2022, 16:04:28 UTC
Previous filing
07 Apr 2022
Next filing
06 Apr 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NEXI Common Stock Award $0 +126,100 +1592% $0.000000 134,023 22 Nov 2022 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Consists of restricted stock units ("RSUs"). Each RSU represents the right to receive one share of common stock upon vesting. The RSUs vest 100% on the 18-month anniversary of the grant date, subject to Mr. Oelke's continued service through the applicable vesting date.
F2 Excludes 223,634 shares of common stock underlying options that are currently exercisable.